CHELMSFORD, MASS. - ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and software solutions, announced today that it has won the Omega NorthFace ScoreBoard Award for a fourth consecutive year. The award is presented annually by the Omega Management Group, a leader in implementing customer satisfaction and retention programs.

“Since 2000, ZOLL’s customer satisfaction levels for technical support and customer service/delivery process have consistently remained high,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “This type of consistency year after year clearly demonstrates the importance we place on customer service as we develop products that help advance the practice of resuscitation.”

The Omega NorthFace ScoreBoard Award is presented annually by Omega Management Corporation to organizations that not only offer exemplary service to their customers, but also center their existence on a deep commitment to exceed all customer expectations.

To qualify for the NorthFace ScoreBoard Award, a company must meet four criteria: 1) senior management commitment to exceeding customer expectations; 2) customer satisfaction program that identifies and corrects customer problems; 3) measuring the level of customer satisfaction with product/service; and 4) achieving an overall score of 4.0 out of 5.0 for a year. In ZOLL’s case, Omega conducted quarterly telephone surveys with 100 customers to determine level of achievement and quantify results.

About Omega Management Group Corporation
Since 1984, Omega has been a leader in providing customer satisfaction and retention programs by successfully partnering with their clients to achieve the goal of World Class Customer Organization. The Chelmsford, Mass.-based company is grounded in the service side of a wide cross section of industries. Omega’s mission is to provide organizations with a competitive advantage by delivering customer intelligence data that increases customer satisfaction and loyalty.

About ZOLL Medical Corporation
ZOLL Medical Corporation (NASDAQ: ZOLL) is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that can help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical data.

ZOLL has operations in the United States, Canada, the United Kingdom, Germany, France, The Netherlands, Australia, and Austria. With direct operations, international offices, and business partners in all of the world’s major markets, ZOLL markets and sells its products in more than 140 countries.